Adrià Cañellas-Socias

6PUBLICATIONS
63CO-AUTHORS
Molecular targetsCancer cell biologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 23, 2025
A Plastic EMP1+ to LGR5+ Cell State Conversion as a Bypass to KRASG12D Pharmacologic Inhibition in Metastatic Colorectal Cancer.

Alessia Centonze, Adrià-Jaume Roura, Meritxell Novillo-Font

|May 28, 2024
Mechanisms of metastatic colorectal cancer.

Adrià Cañellas-Socias, Elena Sancho, Eduard Batlle

|Apr 18, 2024
Membrane to cortex attachment determines different mechanical phenotypes in LGR5+ and LGR5- colorectal cancer cells.

Sefora Conti, Valeria Venturini, Adrià Cañellas-Socias

|Mar 15, 2023
Antitumor T-cell function requires CPEB4-mediated adaptation to chronic endoplasmic reticulum stress.

Marcos Fernández-Alfara, Annarita Sibilio, Judit Martin

|Feb 10, 2023
Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy.

Jenniffer Linares, Anna Sallent-Aragay, Jordi Badia-Ramentol

|Nov 09, 2022
Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells.

Adrià Cañellas-Socias, Carme Cortina, Xavier Hernando-Momblona

Pageof 1